Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–55. https://doi.org/10.1016/s0140-6736(21)02724-0.

Article  CAS  Google Scholar 

O'Neill J. Tackling drug-resistant infections globally: final report and recommendations. 2016. https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf. Accessed May 2024.

Exner M, Bhattacharya S, Christiansen B, Gebel J, Goroncy-Bermes P, Hartemann P, et al. Antibiotic resistance: what is so special about multidrug-resistant Gram-negative bacteria? GMS Hyg Infect Control. 2017;12:Doc05. https://doi.org/10.3205/dgkh000290.

Article  PubMed  PubMed Central  Google Scholar 

Ma J, Song X, Li M, Yu Z, Cheng W, Yu Z, et al. Global spread of carbapenem-resistant Enterobacteriaceae: epidemiological features, resistance mechanisms, detection and therapy. Microbiol Res. 2023;266: 127249. https://doi.org/10.1016/j.micres.2022.127249.

Article  PubMed  CAS  Google Scholar 

Lee YL, Chen HM, Hii IM, Hsueh PR. Carbapenemase-producing Enterobacterales infections: recent advances in diagnosis and treatment. Int J Antimicrob Agents. 2022;59(2): 106528. https://doi.org/10.1016/j.ijantimicag.2022.106528.

Article  PubMed  CAS  Google Scholar 

Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007;20(3):440–58. https://doi.org/10.1128/cmr.00001-07.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Falcone M, Tiseo G, Galfo V, Giordano C, Leonildi A, Marciano E, et al. Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study. Clin Microbiol Infect. 2022;28(2):298.e1-7. https://doi.org/10.1016/j.cmi.2021.06.031.

Article  PubMed  CAS  Google Scholar 

Palzkill T. Metallo-β-lactamase structure and function. Ann N Y Acad Sci. 2013;1277(1):91–104. https://doi.org/10.1111/j.1749-6632.2012.06796.x.

Article  PubMed  CAS  Google Scholar 

Boyd SE, Livermore DM, Hooper DC, Hope WW. Metallo-β-lactamases: structure, function, epidemiology, treatment options, and the development pipeline. Antimicrob Agents Chemother. 2020;64(10):e00397-e420. https://doi.org/10.1128/aac.00397-20.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Falcone M, Tiseo G, Antonelli A, Giordano C, Di Pilato V, Bertolucci P, et al. Clinical features and outcomes of bloodstream infections caused by New Delhi metallo-β-lactamase-producing Enterobacterales during a regional outbreak. Open Forum Infect Dis. 2020;7(2): ofaa011.

Article  PubMed  PubMed Central  Google Scholar 

Pérez-Galera S, Bravo-Ferrer JM, Paniagua M, Kostyanev T, de Kraker MEA, Feifel J, et al. Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA). eClin Med. 2023;57: 101871. https://doi.org/10.1016/j.eclinm.2023.101871.

Article  Google Scholar 

Falcone M, Tiseo G, Carbonara S, Marino A, Di Caprio G, Carretta A, et al. Mortality attributable to bloodstream infections caused by different carbapenem-resistant Gram-negative bacilli: results from a nationwide study in Italy (ALARICO Network). Clin Infect Dis. 2023;76(12):2059–69. https://doi.org/10.1093/cid/ciad100.

Article  PubMed  CAS  Google Scholar 

Zhu C, Li C, Lai CKC, Ng R, Chau KY, Wong KT, et al. Longitudinal genomic characterization of carbapenemase-producing Enterobacteriaceae (CPE) reveals changing pattern of CPE isolated in Hong Kong hospitals. Int J Antimicrob Agents. 2021;58(5): 106430. https://doi.org/10.1016/j.ijantimicag.2021.106430.

Article  PubMed  CAS  Google Scholar 

European Centre for Disease Prevention and Control. Rapid risk assessment: carbapenem-resistant Enterobacteriaceae: first update. 2018. https://www.ecdc.europa.eu/sites/default/files/documents/RRA-Enterobacteriaceae-Carbapenems-European-Union-countries.pdf. Accessed 4 Aug 2025.

Gales AC, Stone G, Sahm DF, Wise MG, Utt E. Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from ATLAS 2017–2019. J Antimicrob Chemother. 2023;78(7):1606–15. https://doi.org/10.1093/jac/dkad127.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tavoschi L, Forni S, Porretta A, Righi L, Pieralli F, Menichetti F, et al. Prolonged outbreak of New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE), Tuscany, Italy, 2018 to 2019. Euro Surveil. 2020;25(6): 2000085.

Article  Google Scholar 

Iaachini S, Fadda G, Monaco M, Errico G, Del Grosso M, Giufre M, et al. CRE: sorveglianza nazionale delle batteriemie da enterobatteri resistenti ai carbapenemi. Dati. 2023. https://www.epicentro.iss.it/antibiotico-resistenza/cpe/RIS-4_2024.pdf. Accessed 27 May 2025.

Zhu Y, Xiao T, Wang Y, Yang K, Zhou Y, Luo Q, et al. Socioeconomic burden of bloodstream infections caused by carbapenem-resistant Enterobacteriaceae. Infect Drug Resist. 2021;14:5385–93. https://doi.org/10.2147/idr.S341664.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bartsch SM, McKinnell JA, Mueller LE, Miller LG, Gohil SK, Huang SS, et al. Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Clin Microbiol Infect. 2017;23(1):48.e9-16. https://doi.org/10.1016/j.cmi.2016.09.003.

Article  PubMed  CAS  Google Scholar 

Claridge JA, Banerjee A, Kelly KB, Leukhardt WH, Carter JW, Haridas M, et al. Bacterial species-specific hospital mortality rate for intra-abdominal infections. Surg Infect (Larchmt). 2014;15(3):194–9. https://doi.org/10.1089/sur.2011.039.

Article  PubMed  Google Scholar 

Kongnakorn T, Eckmann C, Bassetti M, Tichy E, Di Virgilio R, Baillon-Plot N, et al. Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI). Antimicrob Resist Infect Control. 2019;8:204. https://doi.org/10.1186/s13756-019-0652-x.

Article  PubMed  PubMed Central  Google Scholar 

Falcone M, Suardi LR, Tiseo G, Galfo V, Occhineri S, Verdenelli S, et al. Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study). JAC Antimicrob Resist. 2022;4(3): dlac064.

Article  PubMed  PubMed Central  Google Scholar 

Barchitta M, Maugeri A, Favara G, Lio RMS, La Rosa MC, D’Ancona F, et al. The intertwining of healthcare-associated infections and COVID-19 in Italian intensive care units: an analysis of the SPIN-UTI project from 2006 to 2021. J Hosp Infect. 2023;140:124–31. https://doi.org/10.1016/j.jhin.2023.07.021.

Article  PubMed  CAS  Google Scholar 

Falcone M, Giordano C, Leonildi A, Galfo V, Lepore A, Suardi LR, et al. Clinical features and outcomes of infections caused by metallo-β-lactamase-producing Enterobacterales: a 3-year prospective study from an endemic area. Clin Infect Dis. 2023;78(5):1111–9. https://doi.org/10.1093/cid/ciad725.

Article  CAS  Google Scholar 

European Medicines Agency. Emblaveo: summary of product characteristics. https://ec.europa.eu/health/documents/community-register/2024/20240422162367/anx_162367_en.pdf. Accessed 30 Jul 2024.

Carmeli Y, Cisneros JM, Paul M, Daikos GL, Wang M, Torre-Cisneros J, et al. Aztreonam-avibactam versus meropenem for the treatment of serious infections caused by gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial. Lancet Infect Dis. 2025;25(2):218–30. https://doi.org/10.1016/s1473-3099(24)00499-7.

Article  PubMed  CAS  Google Scholar 

ClinicalTrials.gov. Efficacy, safety, and tolerability of ATM-AVI in the treatment of serious infection due to MBL-producing Gram-negative bacteria. https://clinicaltrials.gov/study/NCT03580044. Accessed 4 Aug 2025.

Tiseo G, Brigante G, Giacobbe DR, Maraolo AE, Gona F, Falcone M, et al. Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM). Int J Antimicrob Agents. 2022;60(2): 106611. https://doi.org/10.1016/j.ijantimicag.2022.106611.

Article  PubMed  CAS  Google Scholar 

Falcone M, Daikos GL, Tiseo G, Bassoulis D, Giordano C, Galfo V, et al. Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by metallo-β-lactamase-producing Enterobacterales. Clin Infect Dis. 2021;72(11):1871–8. https://doi.org/10.1093/cid/ciaa586.

Article  PubMed  CAS  Google Scholar 

Cisneros JM, Rosso-Fernández CM, Roca-Oporto C, De Pascale G, Jiménez-Jorge S, Fernández-Hinojosa E, et al. Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (magic bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial. Crit Care. 2019;23(1): 383. https://doi.org/10.1186/s13054-019-2627-y.

Article  PubMed  PubMed Central  Google Scholar